![Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C](https://www.mdpi.com/molecules/molecules-26-05900/article_deploy/html/images/molecules-26-05900-sch001.png)
Molecules, Free Full-Text
![Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C](https://pubs.rsc.org/image/article/2021/MH/d0mh00715c/d0mh00715c-p1_hi-res.gif)
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
![Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12943-021-01346-2/MediaObjects/12943_2021_1346_Fig1_HTML.png)
Delivery of cancer therapies by synthetic and bio-inspired nanovectors, Molecular Cancer
![Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C](https://pubs.rsc.org/en/Content/Image/GA/C5NR04473A)
Doxorubicin-conjugated β-NaYF4:Gd3+/Tb3+ multifunctional, phosphor nanorods: a multi-modal, luminescent, magnetic probe for simultaneous optical and magnetic resonance imaging and an excellent pH-triggered anti-cancer drug delivery nanovehicle
![Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C](https://www.mdpi.com/nanomaterials/nanomaterials-13-01933/article_deploy/html/images/nanomaterials-13-01933-g007.png)
Nanomaterials, Free Full-Text
![Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C](https://pubs.rsc.org/image/article/2021/MH/d0mh00715c/d0mh00715c-f7_hi-res.gif)
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
![Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C](https://www.mdpi.com/molecules/molecules-26-05900/article_deploy/html/images/molecules-26-05900-g003.png)
Molecules, Free Full-Text
![Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnchembio840/MediaObjects/41589_2006_Article_BFnchembio840_Fig1_HTML.jpg)
New approaches to molecular cancer therapeutics
![Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-020-03308-w/MediaObjects/41419_2020_3308_Fig6_HTML.png)
A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature
![Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-017-0004-3/MediaObjects/41392_2017_4_Fig3_HTML.jpg)
Controlled drug delivery vehicles for cancer treatment and their performance
![Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C](https://www.mdpi.com/nanomaterials/nanomaterials-13-01933/article_deploy/html/images/nanomaterials-13-01933-g004.png)
Nanomaterials, Free Full-Text